These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14720207)

  • 1. Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis.
    Klivenyi P; Kiaei M; Gardian G; Calingasan NY; Beal MF
    J Neurochem; 2004 Feb; 88(3):576-82. PubMed ID: 14720207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis.
    Pompl PN; Ho L; Bianchi M; McManus T; Qin W; Pasinetti GM
    FASEB J; 2003 Apr; 17(6):725-7. PubMed ID: 12586733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Klivenyi P; Gardian G; Calingasan NY; Yang L; Beal MF
    J Mol Neurosci; 2003; 21(3):191-8. PubMed ID: 14645986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS.
    Drachman DB; Frank K; Dykes-Hoberg M; Teismann P; Almer G; Przedborski S; Rothstein JD
    Ann Neurol; 2002 Dec; 52(6):771-8. PubMed ID: 12447931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.
    Klivenyi P; Ferrante RJ; Matthews RT; Bogdanov MB; Klein AM; Andreassen OA; Mueller G; Wermer M; Kaddurah-Daouk R; Beal MF
    Nat Med; 1999 Mar; 5(3):347-50. PubMed ID: 10086395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cyclooxygenase-2 in reactive glial cells by the CD40 pathway: relevance to amyotrophic lateral sclerosis.
    Okuno T; Nakatsuji Y; Kumanogoh A; Koguchi K; Moriya M; Fujimura H; Kikutani H; Sakoda S
    J Neurochem; 2004 Oct; 91(2):404-12. PubMed ID: 15447673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creatine supplementation and riluzole treatment provide similar beneficial effects in copper, zinc superoxide dismutase (G93A) transgenic mice.
    Snow RJ; Turnbull J; da Silva S; Jiang F; Tarnopolsky MA
    Neuroscience; 2003; 119(3):661-7. PubMed ID: 12809687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS.
    Zhang W; Narayanan M; Friedlander RM
    Ann Neurol; 2003 Feb; 53(2):267-70. PubMed ID: 12557297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis.
    Petri S; Kiaei M; Kipiani K; Chen J; Calingasan NY; Crow JP; Beal MF
    Neurobiol Dis; 2006 Apr; 22(1):40-9. PubMed ID: 16289867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis.
    Kiaei M; Kipiani K; Petri S; Choi DK; Chen J; Calingasan NY; Beal MF
    J Neurochem; 2005 Apr; 93(2):403-11. PubMed ID: 15816863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Golko-Perez S; Mandel S; Amit T; Kupershmidt L; Youdim MB; Weinreb O
    Neurotox Res; 2016 Feb; 29(2):208-17. PubMed ID: 26581376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intraperitoneal injection of Rofecoxib in a mouse model of ALS.
    Azari MF; Profyris C; Le Grande MR; Lopes EC; Hirst J; Petratos S; Cheema SS
    Eur J Neurol; 2005 May; 12(5):357-64. PubMed ID: 15804265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice.
    Del Signore SJ; Amante DJ; Kim J; Stack EC; Goodrich S; Cormier K; Smith K; Cudkowicz ME; Ferrante RJ
    Amyotroph Lateral Scler; 2009 Apr; 10(2):85-94. PubMed ID: 18618304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2 and ALS.
    McGeer PL
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Sep; 2(3):121-2. PubMed ID: 11771766
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis.
    Almer G; Guégan C; Teismann P; Naini A; Rosoklija G; Hays AP; Chen C; Przedborski S
    Ann Neurol; 2001 Feb; 49(2):176-85. PubMed ID: 11220737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosis.
    Maihöfner C; Probst-Cousin S; Bergmann M; Neuhuber W; Neundörfer B; Heuss D
    Eur J Neurosci; 2003 Sep; 18(6):1527-34. PubMed ID: 14511332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
    Feng X; Peng Y; Liu M; Cui L
    Neuropharmacology; 2012 Feb; 62(2):1004-10. PubMed ID: 22056419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis.
    Drachman DB; Rothstein JD
    Ann Neurol; 2000 Nov; 48(5):792-5. PubMed ID: 11079544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.